Pfizer Inc (PFE) said Friday that it will apply for emergency authorization use of its COVID-19 vaccine in the U.S. in the third week of November, once safety milestone is achieved.
The U.S. Food and Drug Administration wants at least two months of safety data before authorizing emergency use of any experimental coronavirus vaccine.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com